Domov › Ulcerózna kolitída › Texas

Klinické štúdie Ulcerózna kolitída v štáte Texas

33 štúdií pre Ulcerózna kolitída hľadá účastníkov v zariadeniach v štáte Texas.

Mestá v štáte Texas

Oficiálny text štúdie (anglicky)

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
GI Alliance - Lubbock ( Site 0288), Lubbock
Caprock Gastro Research ( Site 0293), Lubbock
a 3 ďalších

Prebieha náborFáza 3

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06651281

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Novel Research - Bellaire /ID# 280925, Bellaire
Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
a 9 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

The Clinical Trials Network CTNX LLC, El Paso
Amel Med LLC, Georgetown
Kelsey Research Foundation, Houston
a 7 ďalších

Prebieha náborFáza 4

Vek 18 až 80 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06581328

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

University of Texas - Southwestern Medical Center /ID# 271835, Dallas

Prebieha náborFáza 3

Vek 2 až 17 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07071519

Confirmatory Clinical Study in Active Ulcerative Colitis

Southern Star Research Institute, San Antonio

Prebieha náborFáza 2

Vek 16 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07296315

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Inquest Clinical Research, Baytown
DHR Health Gastroenterology - Edinburg, Edinburg
Baylor College of Medicine, Houston
a 3 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Xencor Investigative Site, Cedar Park
Xencor Investigative Site, Denton
Xencor Investigative Site, Garland
a 8 ďalších

Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov

Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Site 013, Cedar Park
Site 005, Garland
Site 002, San Antonio
a 2 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Site US-024, Garland
Site US-009, Georgetown
Site US-030, Houston
a 4 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

The University of Texas at Austin, Austin
DFW Clinical Trials, Carrollton
Victorium Clinical Research, Houston
a 3 ďalších

Prebieha náborFáza 3

Vek 12 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07196748

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Cook Childrens Medical Center, Fort Worth

Prebieha náborFáza 3

Vek 3 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06663332

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Local Institution - 0103, Fort Worth
Texas Children's Hospital, Houston

Prebieha náborFáza 2/3

Vek 2 až 17 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Research of San Antonio, San Antonio
Southern Star Research Institute, San Antonio
Tyler Research Institute, Tyler

Prebieha náborFáza 3

Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
a 2 ďalších

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Texas Digestive Disease Consultants - Cedar Park, Cedar Park
GI Alliance - Dallas - Gaston Avenue, Dallas
GI Alliance - Fort Worth, Fort Worth
a 5 ďalších

Prebieha náborFáza 2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

One of a Kind Clinical Research Center - Kingwood, Kingwood
Southern Star Research Institute, San Antonio

Prebieha náborFáza 2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Cook Children's Medical Center, Fort Worth

Prebieha náborFáza 3

Vek 2 až 19 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT04844606

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

GI Alliance - Fort Worth, Fort Worth
GI Alliance - Garland, Garland
Integrity Advanced Therapeutics, Houston
a 4 ďalších

Prebieha náborFáza 2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

GI Alliance - Digestive Health Associates of Texas, Dallas
The University of Texas Health Science Center at Houston, Houston
GI Alliance - Mansfield, Mansfield
a 4 ďalších

Prebieha náborFáza 4

Vek 18 až 65 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

GI Alliance - Lubbock - Site Number: 8400092, Lubbock
Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101, Southlake
a 1 ďalších

Prebieha náborFáza 3

Vek 16 až 80 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Southern Star Research Institute, LLC, San Antonio
Tyler Research Institute, LLC, Tyler

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07577856

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

BAMC, Houston

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT04372108

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Texas Digestive Disease Consultants, Cedar Park
Baylor College of Medicine, Houston

Prebieha náborFáza 2

Vek 18 až 80 · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Inquest Clinical Research - Site Number: 8400144, Baytown
The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
Valley Institute of Research - Site Number: 8400004, Harlingen
a 7 ďalších

Prebieha náborFáza 3

Vek 16 až 80 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07184996